TQ Quiz | GCA, MG, and TED – The Autoimmune Alphabet (Nashville 2024) by Events@optometricedu.com | Sep 26, 2024 | 2024 Nashville, TQ Courses | 0 comments "*" indicates required fields HiddenDate (Hidden) MM slash DD slash YYYY HiddenEvent Date (Hidden) MM slash DD slash YYYY HiddenEvent 60 days past date (Hidden) MM slash DD slash YYYY HiddenEvent Date Difference (Hidden)1. The thyroid is what type of gland?* A - Serous B - Sebaceous C - Exocrine D - Endocrine 2. Which structure of the body has endocrine and exocrine features?* A - Thyroid gland B - Pancreas C - Pituitary gland D - Parathyroid glands 3. In normal thyroid function, what chemical messenger does the pituitary body produce?* A - T3 and T4 B - Thyroid releasing hormone C - Thyroid stimulating hormone D - Calcitonin 4. What is the most common cause of thyroid dysfunction?* A - Cancer B - Autoimmune disease C - Surgically induced D - Pregnancy E - Medication toxicity or side effect 5. Which of the following causes the thyroid eye disease in the congestive autoimmune form phase?* A - Thyroid antibodies B - Triiodothyronine (T3) C - Thyroxine (T4) D - Calcitonin 6. Which thyroid dysfunction accounts for 80% of the thyroid eye disease (TED) cases?* A - Hashimoto's thyroiditis B - Atrophic thyroiditis C - Euthyroid disease D - Hyperthyroid 7. Nervousness, heat intolerance, sweating, tremor, and tachycardia are signs and symptoms of?* A - Hashimoto's thyroiditis B - Atrophic thyroiditis C - Euthyroid disease D - Hyperthyroid 8. Which grading scale grades severity and activity? Also used in the clinical trials and studies for Teprotumumab-trbw (Tepezza).* A - NOSPECS grading system B - YESSPECS grading system C - LEMO classification D - Clinical Activity Score (CAS) 9. Thyroid eye disease is an inflammation of the?* A - Orbit B - Retinal C - Aqueous and vitreous D - Meibomian glands 10. Which term is reserved for the prominence of the eye caused by increased volume of the extra ocular muscles secondary to thyroid disease?* A - Exophthalmos B - Lid retraction C - Periorbital edema D - Optic neuropathy 11. Thyroid eye disease can lead to severe loss of vision in 5.0% of the patients. Which ocular complication of thyroid eye disease is the most likely cause of the severe vision loss?* A - Optic neuropathy B - Periorbital edema C - Restrictive myopathy D - Lid retraction 12. Which biologic drug is indicated for thyroid eye disease?* A - Teprotumumab-trbw (Tepezza) B - Cenegermin–bkbj (Oxervate) C - Tocilizumab (Actemra) D - Adalimumab (Humira) 13. Which of the following mechanisms most closely describes how Teprotumumab-trbw (Tepezza) works?* A - It binds to IGF-1 receptor and blocks its activation and signaling. B - It is an exact copy human nerve growth factor. C - It blocks vascular endothelial growth factor. D - It binds to TNF and blocks its action in the body 14. An adverse drug reaction for Teprotumumab-trbw (Tepezza) is?* A - Hyperglycemia B - Hypoglycemia C - Low blood pressure D - Low intraocular pressure 15. Teprotumumab-trbw (Tepezza) is administrated as?* A - Eye drop B - Orbital injection C - Infusion D - Orally 16. What is the incidence of diplopia in giant cell arteritis?* A - 7% B - 17% C - 27% D - 52% 17. What is considered the earliest age of onset of giant cell arteritis?* A - 40 years B - 50 years C - 60 years D - 72 years 18. Which of the following is not one of the 3 most common tests done for giant cell arteritis?* A - Hemoglobin B - ESR C - CRP D - Platelets 19. Which gland is most likely involved in myasthenia gravis?* A - Pituitary glaucoma B - Pineal gland C - Thymus gland D - Thyroid gland 20. Which test is most sensitive and specific for ocular myasthenia gravis (OMG) detection?* A - ACH-R binding B - ACH-R blocking C - ACH-R modulating D - Anti-Musk Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional Code Nashville 2024 - GCA, MG, and TED – The Autoimmune Alphabet | TQ Credit*After 11/29/2024, pricing will increase to $30. Price: (Past 60 Days) Nashville 2024 - GCA, MG, and TED – The Autoimmune Alphabet | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: Promotional Discount Price: (Past 60 Days) Retake Discount Price: (Past 60 Days) Promotional Discount Price: Credit Card* HiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenRetake Code (HIDDEN) HiddenQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/) HiddenCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
